Bowel function and quality of life after minimally invasive colectomy with D3 lymphadenectomy for right-sided colon adenocarcinoma

Table 3 Assessment of bowel function and medicine use

	Preoperative (n = 57)	3 mo (n = 47)	6 mo (n = 52)	12 mo (n = 52)	18 mo (n = 25)	P value1	P value2
Gas	3.6	3.1	2.3	1.6	0.8	< 0.001	0.023
Leakage	0.4	0.2	0.2	0.1	0	0.025	0.691
Frequency	1.7	1.8	1.2	1.3	0.5	0.014	< 0.001
Fragmentation	2.9	2.2	2.2	1.4	1.2	0.037	0.858
Urgency	3.8	2.6	3.9	2.4	2.0	0.217	0.532
Score	12.4	10.0	9.9	6.8	4.5	< 0.001	0.053
Dysfunction group						0.014	0.028
No	44 (77.2)	41 (87.2)	43 (82.7)	47 (90.4)	24 (96.0)
Minor	5 (8.8)	4 (8.5)	4 (7.7)	3 (5.8)	1 (4.0)
Major	8 (14.0)	2 (4.3)	5 (9.6)	2 (3.8)	0
Medicine	5 (8.8)	6 (12.8)	6 (11.5)	5 (9.6)	2 (8.0)	0.882
Antidiarrheal agent	1 (1.8)	2 (4.3)	1 (1.9)	1 (1.9)	0	0.558
Bulking agent	0	2 (4.3)	1 (1.9)	1 (1.9)	2 (8.0)	0.161
Stool softener	3 (5.3)	4 (8.5)	4 (7.7)	1 (1.9)	2 (8.0)	0.764
Other	1 (1.8)	0	0	3 (5.8)	0	0.447

¹P values correspond to the changes of values over the period.

²P values correspond to the correlation between the scales and medication. Values are presented as mean (range) or n (%).